Does IXEKIZUMAB Cause Candida infection? 142 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Candida infection have been filed in association with IXEKIZUMAB (TALTZ). This represents 0.4% of all adverse event reports for IXEKIZUMAB.
142
Reports of Candida infection with IXEKIZUMAB
0.4%
of all IXEKIZUMAB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Candida infection From IXEKIZUMAB?
Of the 142 reports, 11 (7.7%) required hospitalization, and 2 (1.4%) were considered life-threatening.
Is Candida infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 142 reports have been filed with the FAERS database.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Candida infection?
PREDNISONE (939)
METHOTREXATE (782)
RITUXIMAB (684)
CYCLOPHOSPHAMIDE (662)
TACROLIMUS (656)
METHYLPREDNISOLONE (590)
SECUKINUMAB (569)
ADALIMUMAB (510)
DEXAMETHASONE (506)
PREDNISOLONE (499)
Which IXEKIZUMAB Alternatives Have Lower Candida infection Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID